BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 18539677)

  • 1. Intramedullary application of bone morphogenetic protein in the management of a major bone defect after an Ilizarov procedure.
    Burkhart KJ; Rommens PM
    J Bone Joint Surg Br; 2008 Jun; 90(6):806-9. PubMed ID: 18539677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined treatment of congenital pseudarthrosis of the tibia, including recombinant human bone morphogenetic protein-2: a case series.
    Spiro AS; Babin K; Lipovac S; Stenger P; Mladenov K; Rupprecht M; Rueger JM; Stuecker R
    J Bone Joint Surg Br; 2011 May; 93(5):695-9. PubMed ID: 21511938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human bone morphogenetic protein-2 for grade III open segmental tibial fractures from combat injuries in Iraq.
    Kuklo TR; Groth AT; Anderson RC; Frisch HM; Islinger RB
    J Bone Joint Surg Br; 2008 Aug; 90(8):1068-72. PubMed ID: 18669965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of a congenital pseudarthrosis of the tibia by osteogenic protein-1 (bone morphogenetic protein-7): a case report.
    Anticevic D; Jelic M; Vukicevic S
    J Pediatr Orthop B; 2006 May; 15(3):220-1. PubMed ID: 16601593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic considerations for the use of recombinant human bone morphogenetic protein-2 in open tibial fractures in Europe: the German model.
    Alt V; Heissel A
    Curr Med Res Opin; 2006; 22 Suppl 1():S19-22. PubMed ID: 16882366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone morphogenetic protein 7 in the treatment of congenital pseudarthrosis of the tibia.
    Fabeck L; Ghafil D; Gerroudj M; Baillon R; Delincé P
    J Bone Joint Surg Br; 2006 Jan; 88(1):116-8. PubMed ID: 16365133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is bone lengthening over an intramedullary prosthesis stem possible and safe?
    Romanos E; Ghanem I; Dagher F; Kharrat K
    J Pediatr Orthop B; 2008 Nov; 17(6):307-9. PubMed ID: 18841065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ilizarov treatment of tibial nonunions results in 16 cases.
    Laursen MB; Lass P; Christensen KS
    Acta Orthop Belg; 2000 Jun; 66(3):279-85. PubMed ID: 11033919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of management of tibial non-union defect with Ilizarov fixator.
    Farmanullah ; Khan MS; Awais SM
    J Ayub Med Coll Abbottabad; 2007; 19(3):34-6. PubMed ID: 18444588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone morphogenetic proteins in open fractures: past, present, and future.
    Nauth A; Ristiniemi J; McKee MD; Schemitsch EH
    Injury; 2009 Dec; 40 Suppl 3():S27-31. PubMed ID: 20082787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alopecia universalis treated with bone morphogenetic protein?
    Leslie KS; Shah SN; Darrah C; Cooper A; Valentin-Opran A; Patel AD; Donel ST
    Br J Dermatol; 2006 Jan; 154(1):190-1. PubMed ID: 16403121
    [No Abstract]   [Full Text] [Related]  

  • 12. Biologics in foot and ankle surgery.
    Hawkins BJ
    Foot Ankle Clin; 2010 Dec; 15(4):577-96. PubMed ID: 21056858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of recombinant human bone morphogenetic protein-2 on mandibular distraction osteogenesis.
    Ozeç Y; Oztürk M; Kýlýç E; Yeler H; Göze F; Gümüş C
    J Craniofac Surg; 2006 Jan; 17(1):80-3. PubMed ID: 16432412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human bone morphogenetic proteins in the treatment of fractures.
    Kain MS; Einhorn TA
    Foot Ankle Clin; 2005 Dec; 10(4):639-50, viii. PubMed ID: 16297824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of recombinant human bone morphogenetic protein-2 on mandibular distraction at different rates in an experimental model.
    Cheung LK; Zheng LW
    J Craniofac Surg; 2006 Jan; 17(1):100-8; discussion 109-10. PubMed ID: 16432416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of congenital pseudarthrosis of the tibia with recombinant human bone morphogenetic protein-7 (rhBMP-7). A report of five cases.
    Lee FY; Sinicropi SM; Lee FS; Vitale MG; Roye DP; Choi IH
    J Bone Joint Surg Am; 2006 Mar; 88(3):627-33. PubMed ID: 16510831
    [No Abstract]   [Full Text] [Related]  

  • 17. External fixation of tibial pilon fractures and fracture healing.
    Ristiniemi J
    Acta Orthop Suppl; 2007 Jun; 78(326):3, 5-34. PubMed ID: 17465283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ilizarov external fixation salvage of failed intramedullary fixation of tibia with nail retention.
    Taylor KF; McHale KA
    Am J Orthop (Belle Mead NJ); 2004 Sep; 33(9):461-7. PubMed ID: 15509112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine investigation of rhBMP-2, autogenous bone graft, and rhBMP-2 with autogenous bone graft for the healing of a large segmental tibial defect.
    Boyce AS; Reveal G; Scheid DK; Kaehr DM; Maar D; Watts M; Stone MB
    J Orthop Trauma; 2009; 23(10):685-92. PubMed ID: 19858976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ilizarov external fixation and then nailing in management of infected nonunions of the tibial shaft.
    Emara KM; Allam MF
    J Trauma; 2008 Sep; 65(3):685-91. PubMed ID: 18784585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.